Growth Metrics

C4 Therapeutics (CCCC) Amortizatization of Intangibles (2019 - 2026)

C4 Therapeutics has reported Amortizatization of Intangibles over the past 8 years, most recently at $1.1 million for Q1 2026.

  • For Q1 2026, Amortizatization of Intangibles rose 39.08% year-over-year to $1.1 million; the TTM value through Mar 2026 reached $6.7 million, up 19.82%, while the annual FY2025 figure was $6.4 million, 0.2% changed from the prior year.
  • Amortizatization of Intangibles for Q1 2026 was $1.1 million at C4 Therapeutics, down from $1.4 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $4.0 million in Q3 2022 and troughed at -$3.7 million in Q4 2022.
  • A 5-year average of $1.2 million and a median of $1.4 million in 2024 define the central range for Amortizatization of Intangibles.
  • Biggest five-year swings in Amortizatization of Intangibles: plummeted 2175.0% in 2022 and later soared 797.16% in 2024.
  • Year by year, Amortizatization of Intangibles stood at -$3.7 million in 2022, then skyrocketed by 142.46% to $1.6 million in 2023, then skyrocketed by 34.74% to $2.1 million in 2024, then tumbled by 32.15% to $1.4 million in 2025, then decreased by 23.79% to $1.1 million in 2026.
  • Business Quant data shows Amortizatization of Intangibles for CCCC at $1.1 million in Q1 2026, $1.4 million in Q4 2025, and $3.6 million in Q3 2025.